Concepedia

Alexander Zhebrak

AZ

6

Publications

615

Citations

6

H-Index

2018

Active since

Affiliations

Insilicos (United States)(Current)

Insilico Medicine (United States)

Hong Kong Science and Technology Parks Corporation

Alexander Zhebrak is an author at Insilicos (United States) specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2018–2020

6

Publications

6

Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery

Daniil Polykovskiy, Alexander Zhebrak, Dmitry Vetrov et al. · Molecular Pharmaceutics · 2018 · 278 citations

, , +16

Potential 2019-nCoV 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches

Alex Zhavoronkov, Vladimir Aladinskiy, Alexander Zhebrak et al. · 2020 · 105 citations · Full text

, , +16

Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches

Alex Zhavoronkov, Vladimir Aladinskiy, Alexander Zhebrak et al. · 2020 · 97 citations · Full text

, , +18

Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches

Alex Zhavoronkov, Vladimir Aladinskiy, Alexander Zhebrak et al. · 2020 · 62 citations · Full text

, , +15

Potential Non-Covalent SARS-CoV-2 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches and Reviewed by Human Medicinal Chemist in Virtual Reality

Alex Zhavoronkov, Bogdan Zagribelnyy, Alexander Zhebrak et al. · 2020 · 44 citations · Full text

, , +21

Rows per page

1–5 of 6